Literature DB >> 10468509

The interleukin-1 type I receptor is expressed in human hypothalamus.

E A Hammond1, D Smart, S Toulmond, N Suman-Chauhan, J Hughes, M D Hall.   

Abstract

Several lines of evidence suggest that interleukin-1 (IL-1) acts directly on the central nervous system, probably within the hypothalamus, causing effects such as fever, activation of the immune response and sickness behaviour. IL-1 has also been shown to be involved in the aetiology of several neuronal diseases, including neurodegeneration, stroke and Alzheimer's disease. However, the question as to whether the full-length type I IL-1 receptor (IL-1RI) is expressed in the human hypothalamus has yet to be addressed. Using the polymerase chain reaction, we cloned a full-length cDNA encoding the human hypothalamic IL-1RI from human hypothalamic cDNA. The DNA sequence of the human hypothalamic receptor was identical to that of the human fibroblast IL-1RI. The IL-1RI receptor protein was detected in astrocytes of normal human hypothalamic brain sections using immunocytochemical techniques. To ascertain that the cloned receptor was functional, Chinese hamster ovary (CHO) cells were transfected with a plasmid vector containing the IL-1RI coding region. IL-1RI-mediated-signal transduction was assessed by microphysiometry and activation of p38 MAP (mitogen-activated protein) kinase. We report the first demonstration that both the type I IL-1 transcript and the protein are expressed in the human hypothalamus. The receptor was expressed in a stable CHO cell line, providing a tool with which to embark on a thorough analysis of the signalling mechanisms mediated by IL-1 via this receptor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468509     DOI: 10.1093/brain/122.9.1697

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  4 in total

1.  Neuromodulatory role of endogenous interleukin-1β in acute seizures: possible contribution of cyclooxygenase-2.

Authors:  Robert J Claycomb; Sandra J Hewett; James A Hewett
Journal:  Neurobiol Dis       Date:  2011-08-10       Impact factor: 5.996

2.  Interleukin-1β in Central Nervous System Injury and Repair.

Authors:  Nicole A Jackman; Robert J Claycomb; Sandra J Hewett
Journal:  Eur J Neurodegener Dis       Date:  2012-08

Review 3.  Neuroinflammation in Post-Traumatic Stress Disorder.

Authors:  Dong-Hun Lee; Ji-Young Lee; Dong-Yong Hong; Eun-Chae Lee; Sang-Won Park; Man-Ryul Lee; Jae-Sang Oh
Journal:  Biomedicines       Date:  2022-04-20

4.  A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients.

Authors:  Anne-Li Lind; Di Wu; Eva Freyhult; Constantin Bodolea; Titti Ekegren; Anders Larsson; Mats G Gustafsson; Lenka Katila; Jonas Bergquist; Torsten Gordh; Ulf Landegren; Masood Kamali-Moghaddam
Journal:  PLoS One       Date:  2016-02-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.